Literature DB >> 8580014

Renal function following unilateral nephrectomy for neuroblastoma and Wilms' tumour.

M Schell1, P Cochat, A Hadj-Aïssa, E Bouffet, L Dubourg, M Brunat-Mentigny.   

Abstract

To estimate the side effects of chemotherapy and the influence of age at the time of nephrectomy on renal function, we investigated renal function in 34 uninephrectomised children with neuroblastoma (NB) or Wilms' tumour (WT). The results were compared with 6 controls who underwent nephrectomy for non-malignant disease. Study of renal function was primarily based on the clearance of inulin and para-aminohippuric acid (Cin and CPAH, ml/min per 1.73 m2). No significant differences in Cin/CPAH (mean +/- SD) were found between the NB group (90 +/- 24/421 +/- 95), WT group (85 +/- 17/386 +/- 104) and the controls (93 +/- 13/430 +/- 61). Children with NB and WT were divided into two subgroups according to the theoretical nephrotoxic risk. There was no significant difference in renal function between NB or between WT subgroups. Cumulative cisplatin doses in children with NB did not affect renal function significantly. The age at time of unilateral nephrectomy (< or = 2 years vs. > 2 years) was not associated with a higher risk of renal damage in WT children, whereas in NB children the filtration fraction (Cin:CPAH) was higher in younger children (mean +/- SD: 0.243 +/- 0.023 vs. 0.191 +/- 0.041). In conclusion, uninephrectomised children with NB are supposed to have a higher risk of drug-induced renal impairment compared with those with WT. Our data do not confirm this hypothesis, since renal function was comparable to controls in both groups, except in younger patients with NB who show a high filtration fraction. Since the survival of children with NB has improved, a longer follow-up of their renal function in needed.

Entities:  

Mesh:

Year:  1995        PMID: 8580014     DOI: 10.1007/bf00860940

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  30 in total

1.  Long-term follow-up of ifosfamide renal toxicity in children treated for malignant mesenchymal tumors: an International Society of Pediatric Oncology report.

Authors:  A Suarez; H McDowell; P Niaudet; E Comoy; F Flamant
Journal:  J Clin Oncol       Date:  1991-12       Impact factor: 44.544

2.  Glomerulotubular balance and functional compensation in nephrectomized children.

Authors:  J Simon; I Zamora; S Mendizabal; V Castel; A Lurbe
Journal:  Nephron       Date:  1982       Impact factor: 2.847

3.  Partial reversibility of cisplatin nephrotoxicity in children.

Authors:  P R Brock; D E Koliouskas; T M Barratt; E Yeomans; J Pritchard
Journal:  J Pediatr       Date:  1991-04       Impact factor: 4.406

4.  A comparative study of size and function of the remnant kidney in patients nephrectomized in childhood for Wilms' tumor and hydronephrosis.

Authors:  I Wikstad; B A Pettersson; G Elinder; S Sökücü; A Aperia
Journal:  Acta Paediatr Scand       Date:  1986-05

5.  Lack of age-dependent cisplatin nephrotoxicity.

Authors:  W J Hrushesky; W Shimp; B J Kennedy
Journal:  Am J Med       Date:  1984-04       Impact factor: 4.965

Review 6.  Dosing and side-effects of ifosfamide plus mesna.

Authors:  W P Brade; K Herdrich; U Kachel-Fischer; C E Araujo
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

7.  John Caffey Award: chemotherapy-induced inhibition of compensatory renal growth in the immature mouse.

Authors:  P S Moskowitz; S S Donaldson; E Canty
Journal:  AJR Am J Roentgenol       Date:  1980-03       Impact factor: 3.959

8.  Radiation-induced inhibition of compensatory renal growth in the weanling mouse kidney.

Authors:  S S Donaldson; P S Moskowitz; E L Canty; B Efron
Journal:  Radiology       Date:  1978-08       Impact factor: 11.105

9.  Effects of cisplatin on different measures of glomerular function in the human kidney with special emphasis on high-dose.

Authors:  G Daugaard; N Rossing; M Rørth
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

10.  Acute and cumulative effects of carboplatin on renal function.

Authors:  D T Sleijfer; E F Smit; S Meijer; N H Mulder; P E Postmus
Journal:  Br J Cancer       Date:  1989-07       Impact factor: 7.640

View more
  5 in total

Review 1.  Renal late effects in patients treated for cancer in childhood: a report from the Children's Oncology Group.

Authors:  Deborah P Jones; Sheri L Spunt; Daniel Green; James E Springate
Journal:  Pediatr Blood Cancer       Date:  2008-12       Impact factor: 3.167

2.  Image-defined risk factors for nephrectomy in patients undergoing neuroblastoma resection.

Authors:  Irene Isabel P Lim; Debra A Goldman; Benjamin A Farber; Jennifer M Murphy; Sara J Abramson; Ellen Basu; Stephen Roberts; Michael P LaQuaglia; Anita P Price
Journal:  J Pediatr Surg       Date:  2016-03-02       Impact factor: 2.545

3.  Renal function after ifosfamide, carboplatin and etoposide (ICE) chemotherapy, nephrectomy and radiotherapy in children with Wilms tumour.

Authors:  Najat C Daw; David Gregornik; John Rodman; Neyssa Marina; Jianrong Wu; Larry E Kun; Jesse J Jenkins; Valerie McPherson; Judith Wilimas; Deborah P Jones
Journal:  Eur J Cancer       Date:  2008-11-06       Impact factor: 9.162

4.  Glomerular filtration rate and prevalence of chronic kidney disease in Wilms' tumour survivors.

Authors:  Joanna Stefanowicz; Mateusz Kosiak; Grzegorz Romanowicz; Radosław Owczuk; Elżbieta Adamkiewicz-Drożyńska; Anna Balcerska
Journal:  Pediatr Nephrol       Date:  2011-01-29       Impact factor: 3.714

5.  Early and late adverse renal effects after potentially nephrotoxic treatment for childhood cancer.

Authors:  Esmee Cm Kooijmans; Arend Bökenkamp; Nic S Tjahjadi; Jesse M Tettero; Eline van Dulmen-den Broeder; Helena Jh van der Pal; Margreet A Veening
Journal:  Cochrane Database Syst Rev       Date:  2019-03-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.